Answers are grounded in this paper and cite their sources.
Enflicoxib is a COX-2 selective NSAID shown to be efficacious and safe in the treatment of pain and inflammation associated with canine osteoarthritis (OA) in clinical studies of 6 weeks duration.
No takes yet. Share an insight, caveat, or question.
Homedes et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: